My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 95

    1.

    Impaired germ cell development due to compromised cell cycle progression in Skp2-deficient mice.

    Fotovati A, Nakayama K, Nakayama KI.

    Cell Div. 2006 Apr 7;1:4.PMID: 16759351 [PubMed - in process]Related articlesFree article

    2.

    Renal damage in obstructive nephropathy is decreased in Skp2-deficient mice.

    Suzuki S, Fukasawa H, Kitagawa K, Uchida C, Hattori T, Isobe T, Oda T, Misaki T, Ohashi N, Nakayama K, Nakayama KI, Hishida A, Yamamoto T, Kitagawa M.

    Am J Pathol. 2007 Aug;171(2):473-83. Epub 2007 Jul 9.PMID: 17620370 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.

    Auld CA, Fernandes KM, Morrison RF.

    J Cell Physiol. 2007 Apr;211(1):101-11.PMID: 17096381 [PubMed - indexed for MEDLINE]Related articles

    4.

    Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas.

    Lwin T, Hazlehurst LA, Dessureault S, Lai R, Bai W, Sotomayor E, Moscinski LC, Dalton WS, Tao J.

    Blood. 2007 Sep 1;110(5):1631-8. Epub 2007 May 14.PMID: 17502456 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease.

    Agarwal A, Bumm TG, Corbin AS, O'Hare T, Loriaux M, VanDyke J, Willis SG, Deininger J, Nakayama KI, Druker BJ, Deininger MW.

    Blood. 2008 Sep 1;112(5):1960-70. Epub 2008 Jun 17.PMID: 18559973 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Skp2 promotes adipocyte differentiation via a p27Kip1-independent mechanism in primary mouse embryonic fibroblasts.

    Okada M, Sakai T, Nakamura T, Tamamori-Adachi M, Kitajima S, Matsuki Y, Watanabe E, Hiramatsu R, Sakaue H, Kasuga M.

    Biochem Biophys Res Commun. 2009 Feb 6;379(2):249-54. Epub 2008 Dec 25.PMID: 19109928 [PubMed - indexed for MEDLINE]Related articles

    7.

    The COP9 signalosome regulates Skp2 levels and proliferation of human cells.

    Denti S, Fernandez-Sanchez ME, Rogge L, Bianchi E.

    J Biol Chem. 2006 Oct 27;281(43):32188-96. Epub 2006 Aug 30.PMID: 16943200 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Targeting the p27 E3 ligase SCF(Skp2) results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy.

    Chen Q, Xie W, Kuhn DJ, Voorhees PM, Lopez-Girona A, Mendy D, Corral LG, Krenitsky VP, Xu W, Moutouh-de Parseval L, Webb DR, Mercurio F, Nakayama KI, Nakayama K, Orlowski RZ.

    Blood. 2008 May 1;111(9):4690-9. Epub 2008 Feb 27.PMID: 18305219 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The F box protein S phase kinase-associated protein 2 regulates adipose mass and adipocyte number in vivo.

    Cooke PS, Holsberger DR, Cimafranca MA, Meling DD, Beals CM, Nakayama K, Nakayama KI, Kiyokawa H.

    Obesity (Silver Spring). 2007 Jun;15(6):1400-8.PMID: 17557977 [PubMed - indexed for MEDLINE]Related articles

    10.

    Regulation of the cell cycle inhibitor p27 and its ubiquitin ligase Skp2 in differentiation of human embryonic stem cells.

    Egozi D, Shapira M, Paor G, Ben-Izhak O, Skorecki K, Hershko DD.

    FASEB J. 2007 Sep;21(11):2807-17. Epub 2007 May 2.PMID: 17475922 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Skp2 regulates G2/M progression in a p53-dependent manner.

    Hu R, Aplin AE.

    Mol Biol Cell. 2008 Nov;19(11):4602-10. Epub 2008 Aug 20.PMID: 18716061 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Essential role of Skp2-mediated p27 degradation in growth and adaptive expansion of pancreatic beta cells.

    Zhong L, Georgia S, Tschen SI, Nakayama K, Nakayama K, Bhushan A.

    J Clin Invest. 2007 Oct;117(10):2869-76.PMID: 17823659 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein.

    Huang HC, Way TD, Lin CL, Lin JK.

    Endocrinology. 2008 Dec;149(12):5972-83. Epub 2008 Aug 21.PMID: 18719023 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    S-phase kinase-associated protein-2 (Skp2) promotes vascular smooth muscle cell proliferation and neointima formation in vivo.

    Wu YJ, Sala-Newby GB, Shu KT, Yeh HI, Nakayama KI, Nakayama K, Newby AC, Bond M.

    J Vasc Surg. 2009 Nov;50(5):1135-42.PMID: 19878790 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Evidence for cytosolic p27(Kip1) ubiquitylation and degradation during adipocyte hyperplasia.

    Auld CA, Morrison RF.

    Obesity (Silver Spring). 2006 Dec;14(12):2136-44.PMID: 17189539 [PubMed - indexed for MEDLINE]Related articles

    16.

    Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer.

    Hershko DD.

    Cancer. 2008 Apr 1;112(7):1415-24. Review.PMID: 18260093 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells.

    Shapira M, Kakiashvili E, Rosenberg T, Hershko DD.

    Breast Cancer Res. 2006;8(4):R46.PMID: 16859513 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Differential effects of doxorubicin treatment on cell cycle arrest and Skp2 expression in breast cancer cells.

    Bar-On O, Shapira M, Hershko DD.

    Anticancer Drugs. 2007 Nov;18(10):1113-21.PMID: 17893511 [PubMed - indexed for MEDLINE]Related articles

    19.

    Skp2 inversely correlates with p27 and tuberin in transformed cells.

    Rosner M, Hanneder M, Siegel N, Valli A, Fuchs C, Hengstschläger M.

    Amino Acids. 2009 Jul;37(2):257-62. Epub 2008 Jul 6.PMID: 18604603 [PubMed - indexed for MEDLINE]Related articles

    20.

    SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.

    Calvisi DF, Ladu S, Pinna F, Frau M, Tomasi ML, Sini M, Simile MM, Bonelli P, Muroni MR, Seddaiu MA, Lim DS, Feo F, Pascale RM.

    Gastroenterology. 2009 Nov;137(5):1816-26.e1-10. Epub 2009 Aug 15.PMID: 19686743 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk